Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Amortizatization of Intangibles (2022 - 2025)

Catalyst Pharmaceuticals (CPRX) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $37.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortizatization of Intangibles rose 298.8% year-over-year to $37.3 million, compared with a TTM value of $37.5 million through Dec 2025, changed 0.32%, and an annual FY2025 reading of $37.5 million, changed 0.32% over the prior year.
  • Amortizatization of Intangibles was $37.3 million for Q4 2025 at Catalyst Pharmaceuticals, up from -$18.5 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $37.3 million in Q4 2025 and bottomed at -$24.8 million in Q4 2023.
  • Average Amortizatization of Intangibles over 4 years is $6.1 million, with a median of $9.3 million recorded in 2024.
  • The sharpest move saw Amortizatization of Intangibles plummeted 4540.37% in 2023, then soared 298.8% in 2025.
  • Year by year, Amortizatization of Intangibles stood at -$535000.0 in 2022, then tumbled by 4540.37% to -$24.8 million in 2023, then soared by 137.64% to $9.3 million in 2024, then skyrocketed by 298.8% to $37.3 million in 2025.
  • Business Quant data shows Amortizatization of Intangibles for CPRX at $37.3 million in Q4 2025, -$18.5 million in Q3 2025, and $9.3 million in Q2 2025.